Ligand validation:3WY6

NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3WY6_NHE_A_403	95%	5%	0.071	0.974	2.44	2.79	3	7	0	0	100%	0.85
3WY6_NHE_A_405	81%	3%	0.108	0.961	2.54	3.65	2	5	1	0	100%	0.7
3WY6_NHE_A_404	70%	3%	0.106	0.923	2.95	3.33	2	9	1	0	100%	0.86
3WY6_NHE_A_406	19%	7%	0.192	0.786	2.17	2.57	2	6	6	0	100%	0.74
3WXP_NHE_A_404	99%	10%	0.052	0.986	1.81	2.52	4	7	0	0	100%	0.94
3WR0_NHE_A_402	97%	6%	0.068	0.984	2.29	2.79	4	6	0	0	100%	0.84
3WQ1_NHE_A_404	97%	15%	0.065	0.98	1.77	1.99	3	6	0	0	100%	0.84
3WQ0_NHE_A_404	96%	27%	0.071	0.98	1.7	1.27	4	1	0	0	100%	0.82
3VGI_NHE_A_322	93%	22%	0.079	0.973	1.71	1.55	2	3	0	0	100%	0.8
5TSP_NHE_A_1001	99%	51%	0.053	0.99	0.93	0.98	-	1	0	0	100%	1
2DSY_NHE_C_1001	99%	34%	0.051	0.979	1.49	1.14	1	1	0	0	100%	1
3WH6_NHE_A_505	99%	13%	0.056	0.984	1.25	2.71	2	5	0	0	100%	1
8WNA_NHE_A_502	98%	70%	0.059	0.983	0.38	0.78	-	-	0	0	100%	1
3O1W_NHE_B_488	98%	17%	0.063	0.985	1.36	2.21	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.